navigating biosimilars: introduction
Published 6 years ago • 10 plays • Length 0:50Download video MP4
Download video MP3
Similar videos
-
8:32
navigating biosimilars: implications for clinicians (red line)
-
6:31
navigating biosimilars: patient education (green line)
-
3:39
navigating biosimilars: biologics landscape (orange line)
-
10:00
navigating biosimilars: biologics and biosimilars (gray line)
-
10:58
navigating biosimilars: us regulatory requirements (yellow line)
-
8:03
navigating biosimilars: extrapolation, naming, substitution (blue line)
-
0:50
introduction: biosimilars—advances in research and development
-
35:31
understanding biosimilars: how the availability of biosimilars will impact clinical practice
-
16:59
biosimilars
-
30:20
the process matters
-
4:20
the biosimilar development process
-
0:19
biosimilars—advances in research and development
-
3:48
module 2: biosimilars—advances in research and development
-
6:24
module 4: biosimilars—advances in research and development
-
4:46
module 3: biosimilars—advances in research and development
-
8:10
module 6: biosimilars—advances in research and development
-
13:32
01 introduction to biosimilars
-
4:32
module 5: biosimilars—advances in research and development
-
1:58
practical considerations for introducing biosimilars
-
57:53
biosimilars: what you need to know
-
2:04
biosimilars: the path to approval